HLscience Co. Ltd (KQ:239610) — Market Cap & Net Worth
Market Cap & Net Worth: HLscience Co. Ltd (239610)
HLscience Co. Ltd (KQ:239610) has a market capitalization of $18.26 Million (₩26.94 Billion) as of August 5, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #25361 globally and #1854 in its home market, demonstrating a -4.17% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying HLscience Co. Ltd's stock price ₩5290.00 by its total outstanding shares 5092951 (5.09 Million). See how much does HLscience Co. Ltd reinvest in capital to understand how much of operating cash flow is reinvested back into capital assets.
HLscience Co. Ltd Market Cap History: 2016 to 2026
HLscience Co. Ltd's market capitalization history from 2016 to 2026. Data shows change from $88.84 Million to $18.26 Million (-17.37% CAGR).
Index Memberships
HLscience Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$206.59 Billion | 0.01% | #987 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$206.59 Billion | 0.01% | #987 of 1384 |
Weight: HLscience Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
HLscience Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how HLscience Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
HLscience Co. Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $88.84 Million | $40.93 Billion | $6.07 Billion | 0.00x | 0.01x |
| 2017 | $102.91 Million | $40.20 Billion | $4.94 Billion | 0.00x | 0.02x |
| 2018 | $134.74 Million | $64.11 Billion | $10.86 Billion | 0.00x | 0.01x |
| 2019 | $172.28 Million | $128.26 Billion | $19.74 Billion | 0.00x | 0.01x |
| 2020 | $149.97 Million | $143.04 Billion | $19.64 Billion | 0.00x | 0.01x |
| 2021 | $120.46 Million | $104.38 Billion | $13.54 Billion | 0.00x | 0.01x |
| 2022 | $64.20 Million | $52.76 Billion | $1.59 Billion | 0.00x | 0.04x |
| 2023 | $55.02 Million | $25.59 Billion | -$1.38 Billion | 0.00x | N/A |
| 2024 | $42.59 Million | $17.66 Billion | -$7.88 Billion | 0.00x | N/A |
Competitor Companies of 239610 by Market Capitalization
Companies near HLscience Co. Ltd in the global market cap rankings as of August 5, 2026.
Key companies related to HLscience Co. Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #504 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #543 globally with a market cap of $49.47 Billion USD ( CN¥338.09 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #549 globally with a market cap of $48.78 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #504 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #543 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $49.47 Billion | CN¥53.00 |
| #549 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $42.97 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €14.70 |
HLscience Co. Ltd Historical Marketcap From 2016 to 2026
Between 2016 and today, HLscience Co. Ltd's market cap moved from $88.84 Million to $ 18.26 Million, with a yearly change of -17.37%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩18.26 Million | -34.61% |
| 2025 | ₩27.92 Million | -34.44% |
| 2024 | ₩42.59 Million | -22.58% |
| 2023 | ₩55.02 Million | -14.30% |
| 2022 | ₩64.20 Million | -46.71% |
| 2021 | ₩120.46 Million | -19.68% |
| 2020 | ₩149.97 Million | -12.95% |
| 2019 | ₩172.28 Million | +27.86% |
| 2018 | ₩134.74 Million | +30.93% |
| 2017 | ₩102.91 Million | +15.84% |
| 2016 | ₩88.84 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 4th, 2026 the market cap of HLscience Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $18.26 Million USD |
| MoneyControl | $18.26 Million USD |
| MarketWatch | $18.26 Million USD |
| marketcap.company | $18.26 Million USD |
| Reuters | $18.26 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About HLscience Co. Ltd
HLscience Co., Ltd. manufactures and sells health functional foods in South Korea. The company offers organic barley grassjuice powder one day, queen's pomegranate jin, Super LuzieA+ Astaxanthin, Dr. Superkhan, HL-JOINT 100 for Joint & Cartilage Premium, Dr. Green Propolis, morosil diet fit, skin master secret, enerlinger vitamin D, PS300 formulated by doctor, Skin Master P-estro, and Dr. Prebiot… Read more